Venclexta 100 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F21WK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,098
Award facts
- Contract value 100% obligated
- $31,098.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $31,098.24 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120-count units) with a firm fixed-price structure. The contract, which carries no set-aside designation, was competitively awarded on February 4, 2026, with an ultimate completion date of February 26, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which is a child contract under the parent organization Cencora, Inc. (doing business as AmerisourceBergen). This delivery order is executed under a larger Indefinite Delivery Contract with the DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
Venclexta is a specialty pharmaceutical product utilized in oncology treatment regimens, and this delivery order supports the Defense Logistics Agency's mission to supply critical medications to military healthcare programs globally, including military treatment facilities and veteran healthcare systems. AmerisourceBergen's substantial IDC with DLA enables the company to serve as a comprehensive pharmaceutical prime vendor, providing a wide range of brand-name and generic medications, specialty drugs, and medical supplies across multiple therapeutic domains to support the Department of Defense healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26F21WK?
SPE2DR26F21WK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F21WK worth?
The government has obligated $31,098 on SPE2DR26F21WK.
Is contract SPE2DR26F21WK an order under another contract?
Yes. SPE2DR26F21WK is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F21WK competed?
The extent of competition for SPE2DR26F21WK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award